Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54518, first published .
Key Considerations for Designing Clinical Studies to Evaluate Digital Health Solutions

Key Considerations for Designing Clinical Studies to Evaluate Digital Health Solutions

Key Considerations for Designing Clinical Studies to Evaluate Digital Health Solutions

Authors of this article:

Elaina Bolinger1 Author Orcid Image ;   Benoit Tyl2 Author Orcid Image

Elaina Bolinger   1 * , PhD ;   Benoit Tyl   2 * , MD

1 Integrated Evidence Generation & Business Innovation, Bayer AG, Berlin, Germany

2 Integrated Evidence Generation & Business Innovation, Bayer HealthCare SAS, La Garenne Colombes, France

*all authors contributed equally

Corresponding Author:

  • Benoit Tyl, MD
  • Integrated Evidence Generation & Business Innovation
  • Bayer HealthCare SAS
  • 10 Place de Belgique
  • La Garenne Colombes, F-92254
  • France
  • Phone: 33 6 80 29 07 79
  • Email: benoit.tyl@bayer.com